| scholarly article | Q13442814 |
| P2093 | author name string | G Deng | |
| Y S Kim | |||
| A Chen | |||
| J Hong | |||
| H S Chae | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2029-2033 | |
| P577 | publication date | 1999-05-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression | |
| P478 | volume | 59 |
| Q24792846 | A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines |
| Q33317627 | A novel method to quantify local CpG methylation density by regional methylation elongation assay on microarray |
| Q35013990 | A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory |
| Q35566861 | A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia |
| Q33518543 | Activin signaling in microsatellite stable colon cancers is disrupted by a combination of genetic and epigenetic mechanisms. |
| Q28298882 | Alterations of copy number of methylation pattern in mismatch repair genes by methylation specific-multiplex ligation-dependent probe amplification in cases of colon cancer |
| Q45805261 | Analysis of mismatch repair gene mutations in Turkish HNPCC patients. |
| Q51449182 | Association between methylation in mismatch repair genes, V600E BRAF mutation and microsatellite instability in colorectal cancer patients |
| Q43688934 | BRAF mutation in sporadic colorectal cancer and Lynch syndrome. |
| Q41056167 | BRAF mutation-specific promoter methylation of FOX genes in colorectal cancer |
| Q43226742 | Cancer epigenetics: new therapies and new challenges. |
| Q55314343 | Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability. |
| Q36463826 | Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors. |
| Q54551065 | Clinicopathologic and molecular features of sporadic microsatellite- and chromosomal-stable colorectal cancers. |
| Q89723158 | Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma |
| Q36081155 | ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing |
| Q37447203 | Colorectal Choriocarcinoma in a Patient with Probable Lynch Syndrome |
| Q33291970 | Colorectal carcinogenesis: road maps to cancer |
| Q33729779 | Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin |
| Q34101774 | Comparative features of colorectal and gastric cancers with microsatellite instability in Chinese patients |
| Q46100093 | Constitutional MLH1 methylation presenting with colonic polyposis syndrome and not Lynch syndrome |
| Q24645280 | CpG methylation plays a vital role in determining tissue- and cell-specific expression of the human cell-death-inducing DFF45-like effector A gene through the regulation of Sp1/Sp3 binding |
| Q35878544 | DNA hypermethylation appears early and shows increased frequency with dysplasia in Lynch syndrome-associated colorectal adenomas and carcinomas |
| Q42261678 | DNA methylation in promoter region as biomarkers in prostate cancer |
| Q33621598 | DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells |
| Q30985494 | Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists |
| Q36813981 | Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors |
| Q64109038 | Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient |
| Q33892398 | Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition? |
| Q28303873 | Endometrial cancer and Lynch syndrome: clinical and pathologic considerations |
| Q38123671 | Endometrial tumour BRAF mutations and MLH1 promoter methylation as predictors of germline mismatch repair gene mutation status: a literature review |
| Q90197000 | Enhanced CRISPR-based DNA demethylation by Casilio-ME-mediated RNA-guided coupling of methylcytosine oxidation and DNA repair pathways |
| Q37200574 | Epigenetic Loss of MLH1 Expression in Normal Human Hematopoietic Stem Cell Clones is Defined by the Promoter CpG Methylation Pattern Observed by High-Throughput Methylation Specific Sequencing |
| Q90221699 | Epigenetic Modifications Compromise Mitochondrial DNA Quality Control in the Development of Diabetic Retinopathy |
| Q33855895 | Epigenetic changes (aberrant DNA methylation) in colorectal neoplasia |
| Q36549885 | Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers |
| Q37357503 | Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer |
| Q24812104 | Epigenetics of cervical cancer. An overview and therapeutic perspectives |
| Q36643558 | Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability. |
| Q54542839 | Externalization of Saw-Tooth Architecture in Small Serrated Polyps Implies the Presence of Methylation of IGFBP7 |
| Q34627551 | Fatty acid binding protein 3 (fabp3) is associated with insulin, lipids and cardiovascular phenotypes of the metabolic syndrome through epigenetic modifications in a Northern European family population |
| Q37103121 | Feasibility of screening for Lynch syndrome among patients with colorectal cancer |
| Q36623407 | Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer |
| Q35810106 | Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers |
| Q37122495 | Genetic diagnosis strategy of hereditary non-polyposis colorectal cancer |
| Q21563514 | Genomic variability within an organism exposes its cell lineage tree |
| Q35653610 | Germline promoter hypermethylation of tumor suppressor genes in gastric cancer |
| Q33723714 | Global methylation and promoter-specific methylation of the P16, SOCS-1, E-cadherin, P73 and SHP-1 genes and their expression in patients with multiple myeloma during active disease and remission |
| Q24292710 | HOXA5 regulates hMLH1 expression in breast cancer cells |
| Q44335624 | How Helpful Is Age at Colorectal Cancer Onset in Finding HNPCC? |
| Q36539162 | Hypermethylated MAL gene - a silent marker of early colon tumorigenesis |
| Q60928870 | Hypermethylation of multiple Wnt antagonist genes in gastric neoplasia: Is H pylori infection blasting fuse? |
| Q38282399 | Hypermethylation of the hMLH1 gene promoter in solitary and multiple gastric cancers with microsatellite instability |
| Q96133145 | Identification of High-Frequency Methylation Sites in RNF180 Promoter Region Affecting Expression and Their Relationship with Prognosis of Gastric Cancer |
| Q36906164 | Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study. |
| Q36697095 | Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer. |
| Q28183803 | Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples |
| Q37298574 | Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing |
| Q36947800 | Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients |
| Q34620502 | Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer |
| Q36380153 | Lynch syndrome associated with two MLH1 promoter variants and allelic imbalance of MLH1 expression |
| Q34650716 | MLH1 Promoter Methylation Frequency in Colorectal Cancer Patients and Related Clinicopathological and Molecular Features |
| Q34512457 | MLH1 Region Polymorphisms Show a Significant Association with CpG Island Shore Methylation in a Large Cohort of Healthy Individuals |
| Q36213262 | MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria |
| Q36035692 | MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study |
| Q47229202 | MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAFV600E mutation. |
| Q36695748 | MSH6 missense mutations are often associated with no or low cancer susceptibility |
| Q34225341 | Metastatic suppressor genes inactivated by aberrant methylation in gastric cancer |
| Q33947093 | Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome. |
| Q28364163 | Methylation matters |
| Q36208014 | Methylation of Breast Cancer Predisposition Genes in Early-Onset Breast Cancer: Australian Breast Cancer Family Registry |
| Q36644067 | Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer |
| Q40137519 | Methylation of the BIN1 gene promoter CpG island associated with breast and prostate cancer |
| Q33775531 | Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis. |
| Q34227653 | Microsatellite instability and ploidy status define three categories with distinctive prognostic impact in endometrioid endometrial cancer |
| Q33791731 | Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel |
| Q38392332 | Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network |
| Q34338885 | Multiplexed profiling of candidate genes for CpG island methylation status using a flexible PCR/LDR/Universal Array assay |
| Q36359174 | Parallel assessment of CpG methylation by two-color hybridization with oligonucleotide arrays |
| Q37288374 | Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers |
| Q28534843 | Reassembly of nucleosomes at the MLH1 promoter initiates resilencing following decitabine exposure |
| Q85739124 | Regulation of MLH1 mRNA and protein expression by promoter methylation in primary colorectal cancer: a descriptive and prognostic cancer marker study |
| Q37166903 | Role of caspases in 5-FU and selenium-induced growth inhibition of colorectal cancer cells |
| Q36230771 | Sessile serrated adenoma shares similar genetic and epigenetic features with microsatellite unstable colon cancer in a location-dependent manner |
| Q30361259 | Silencing-specific methylation and single nucleotide polymorphism of hMLH1 promoter in gastric carcinomas. |
| Q30453828 | Simultaneous detection of CpG methylation and single nucleotide polymorphism by denaturing high performance liquid chromatography |
| Q34055785 | Spreading of Alu Methylation to the Promoter of the MLH1 Gene in Gastrointestinal Cancer |
| Q36530688 | Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers |
| Q28247866 | The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotype |
| Q36947020 | The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer |
| Q37692625 | The dynamic DNA methylation landscape of the mutL homolog 1 shore is altered by MLH1-93G>A polymorphism in normal tissues and colorectal cancer |
| Q90149797 | The polymorphic variant rs1800734 influences methylation acquisition and allele-specific TFAP4 binding in the MLH1 promoter leading to differential mRNA expression |
| Q92416866 | The prevalence and persistence of aberrant promoter DNA methylation in benzene-exposed Chinese workers |
| Q35749254 | The relationship between hypomethylation and CpG island methylation in colorectal neoplasia |
| Q37902054 | Therapeutic strategies to enhance the anticancer efficacy of histone deacetylase inhibitors. |
| Q49163294 | Topographic, histological and molecular study of aberrant crypt foci identified in human colon in different clinical groups |
| Q39354975 | hMLH1 promoter hypermethylation and MSI status in human endometrial carcinomas with and without metastases |
| Q35739695 | hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications |
Search more.